STENDRA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Vivus Llc. The primary component is Avanafil.
Product ID | 62541-502_e10a546c-9a9c-1f78-e053-2a95a90a40d3 |
NDC | 62541-502 |
Product Type | Human Prescription Drug |
Proprietary Name | STENDRA |
Generic Name | Avanafil |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2022-01-01 |
Marketing Category | NDA / |
Application Number | NDA202276 |
Labeler Name | Vivus LLC |
Substance Name | AVANAFIL |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
62541-501 | STENDRA | Avanafil |
62541-502 | STENDRA | Avanafil |
62541-503 | STENDRA | Avanafil |
72384-751 | Stendra | avanafil |
72384-752 | Stendra | avanafil |
72384-753 | Stendra | avanafil |
76299-320 | Stendra | avanafil |
76299-321 | Stendra | avanafil |
76299-322 | Stendra | avanafil |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
STENDRA 85565411 4526269 Live/Registered |
METUCHEN PHARMACEUTICALS, LLC 2012-03-09 |